Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-06

Clinical Trial Update: Gaucherite - A Study to Stratify Gaucher Disease

View source ↗

Summary

This entry describes the Gaucherite study to stratify Gaucher disease (types I and III), which is currently recruiting under Cambridge University Hospitals NHS …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Gaucher Disease, Type I, Gaucher Disease, Type III | Status: RECRUITING